key: cord-1035858-ld9d39fi authors: Li, Tao; Chung, Hye Kyung; Pireku, Papa K.; Beitzel, Brett F.; Sanborn, Mark A.; Tang, Cynthia Y.; Hammer, Richard; Ritter, Detlef; Wan, XiuFeng; Berry, Irina Maljkovic; Hang, Jun title: Rapid High Throughput Whole Genome Sequencing of SARS-CoV-2 by using One-step RT-PCR Amplification with Integrated Microfluidic System and Next-Gen Sequencing date: 2020-11-05 journal: bioRxiv DOI: 10.1101/2020.11.04.369165 sha: 9dd86c799a60da7947cc8293818e9597ca6d8fc6 doc_id: 1035858 cord_uid: ld9d39fi The long-lasting global COVID-19 pandemic demands timely genomic investigation of SARS-CoV-2 viruses. Here we report a simple and efficient workflow for whole genome sequencing utilizing one-step RT-PCR amplification on a microfluidic platform, followed by MiSeq amplicon sequencing. The method uses Fluidigm IFC and instruments to amplify 48 samples with 39 pairs of primers in a single step. Application of this method on RNA samples from both viral isolate and clinical specimens demonstrate robustness and efficiency of this method in obtaining the full genome sequence of SARS-CoV-2. ABSTRACT 23 The long-lasting global COVID-19 pandemic demands timely genomic investigation of CoV-2 viruses. Here we report a simple and efficient workflow for whole genome sequencing 25 utilizing one-step RT-PCR amplification on a microfluidic platform, followed by MiSeq demand more genomic data to be produced using cost-effective and quality-consistent 41 methodology (9-12). Targeted whole genome amplification and next-generation sequencing (NGS) techniques have 43 been used in sequencing SARS-CoV-2 genomes (8, 10, 13) . In contrast to the high throughput 44 capacity of NGS, using a conventional multiplexing reverse transcription and polymerase chain 45 reaction (RT-PCR) procedures to amplify the large 30 Kb viral genomic RNA of SARS-CoV-2 46 is tedious, technically challenging, and has variable contamination risks. A rapid and streamlined 47 approach with fewer manual steps to obtain whole genome amplicons suitable for NGS is 48 desired. In this study, we utilize an integrated microfluidic nucleic acid amplification system (14), custom 50 primer design, and a one-step RT-PCR program to amplify whole SARS-CoV-2 genomes. After 51 NGS of the amplicons, an in-house developed bioinformatics pipeline is used to rapidly obtain 52 genome sequences with graphic summaries for data and results visualization. The NGS libraries were prepared using Illumina DNA Flex Library kit (Illumina, CA, USA). DNA was fragmentized by tagmentation for 15 mins followed by indexing and library 91 amplification, with 6 cycles used for 25 ng of amplicon or 12 cycles used for 1-9 ng of amplicon. The libraries were quantified by using Agilent Tapestation and DNA D5000 kit and then pooled Table 1 , MiSeq data for the quadruplicated R4717 RNA serial dilutions described above were assembled 133 using ngs_mapper pipeline with SARS-CoV-2 complete genome sequence NC_045512.2 as the 134 mapping reference. As expected, genome assembly results correlated well with SARS-CoV-2 135 copy numbers in each sample. For reactions with 10 4 or higher SARS-CoV-2 RNA copies, 136 complete genome sequences were readily obtained, and importantly, they had uniform coverage 137 depth across the genome with the peaks matching the regions of amplicon alignment (Figure 2) . 138 For reactions with 10 3 copies of SARS-CoV-2 RNA, the assembled genome sequences were Fluidigm one-step RT-PCR protocol was applied to SARS-CoV-2 RNA of highly varied titers. For SARS-CoV-2 isolate R4717 RNA 10× dilutions (Figure 1) , a total of 14 full genomes were 159 assembled and curated. All the full genome consensus sequences were identical except for two Even before the disease was named as COVID-19, the sequence was swiftly determined using 168 next-gen sequencing technologies and SARS-CoV-2 was identified as the causative pathogen for 169 the emerging acute respiratory disease (5, 22). The first sequence was made publicly available 170 immediately with a massive number of sequences subsequently generated and shared, which has 171 greatly facilitated research and development (23-25). All the efforts in developing, improving, 172 and sharing materials and/or methods has played an essential role in sequence-based 173 investigations. All the known sequencing protocols use conventional PCR apparatuses with 174 differences in design and selection of primers and reaction parameters. In this study, we applied 175 one-step RT-PCR protocol on a microfluidic platform (14) to establish a convenient workflow 176 with throughput, speed, simplicity, consistency, and yield suitable for COVID-19 genome 177 sequencing. Fluidigm Access Array IFC holds 48 RNA samples (inlets) and 48 primer pairs 178 (inlets). Steps for mixing sample with primers are obviated, which not only substantially reduces 179 pipetting manipulation but also effectively mitigates the chance of sample-to-sample cross-180 contamination. In this report, we selected 39 primer pairs to obtain even genome coverage. Nine Genome coverage and sequence mapping alignment depth for MiSeq reads data. SARS-CoV-2 isolate R4717 RNA serial dilutions were subjected to Fluidigm RT-PCR amplification and MiSeq sequencing. Data were mapped using NC_045512.2 as reference. A. Genome coverage for 10× serial dilutions of R4717 RNA from 1.0E+06 (top) to 1 (bottom) copies. Mapping depth was indicated in colors, green for normal (depth ≥ 10), cyan for dip (depth 1-10), red for gap. Results for four replicates were shown. B. Sequence mapping graphs for 10 6 , 10 5 , 10 4 and 10 3 copies of RNA from one set of serial dilutions. Characteristics of SARS-CoV-2 and COVID-19 Overview: The history 252 and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS The Novel Coronavirus: A Bird's Eye View Return of the Coronavirus: 2019-nCoV. Viruses 12 A novel coronavirus outbreak of global health 258 concern Genomic 262 characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and 263 receptor binding Coast-to-Coast Spread of SARS-CoV-2 during the Early 269 Epidemic in the United States The emergence of SARS-CoV-2 in Europe and North America Revealing COVID-19 276 transmission in Australia by SARS-CoV-2 genome sequencing and agent-based modeling Rapid SARS-CoV-2 whole-282 genome sequencing and analysis for informed public health decision-making in the Netherlands Genome Characterization of SARS-CoV-2 from COVID-19 Cases in Northern Italy Genome-wide analysis of SARS-CoV-2 virus strains circulating worldwide 289 implicates heterogeneity On Behalf Of Iss Covid-Study G. 2020. Whole genome and 293 phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in Somatic Mutation Screening Using Archival Formalin-Fixed, Paraffin-Embedded Tissues by 298 Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR A new coronavirus 305 associated with human respiratory disease in China Trimmomatic: a flexible trimmer for Illumina sequence 307 data Fast and accurate short read alignment with Burrows-Wheeler transform 311 Integrative genomics viewer MEGA7: Molecular Evolutionary Genetics Analysis Version 313 7.0 for Bigger Datasets MUSCLE: multiple sequence alignment with high accuracy and high throughput Note from the editors: novel coronavirus (2019-nCoV). Euro 317 Surveill 25 Assays for laboratory confirmation of novel human 321 coronavirus (hCoV-EMC) infections Comparative Performance of SARS-CoV-2 Detection Assays Using Seven 324 Different Primer-Probe Sets and One Assay Kit A highly conserved 326 cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV Disentangling primer interactions 329 improves SARS-CoV-2 genome sequencing by multiplex tiling PCR Sequencing of Severe Acute Respiratory Syndrome Coronavirus 2 A Comparison of Whole Genome Sequencing of SARS-CoV-2 Using Amplicon-336 Based Sequencing, Random Hexamers, and Bait Capture